newsfilter
← Latest News
GlobeNewswire·

Thiogenesis Therapeutics, Corp. to Present at the Life Sciences Virtual Investor Forum December 11th

SAN DIEGO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Thiogenesis Therapeutics, Corp. (TSXV:TTI) (OTCQX:TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation sulfur-based